BEDFORD, Mass., March 12, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (ANIK), a global leader in the Osteoarthritis ("OA") Pain Management and Regenerative Solutions space focused on early ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
RevoMotion™ Reverse Shoulder System showing smallest diameter threaded glenoid baseplate RevoMotion™ Reverse Shoulder System showing smallest diameter threaded glenoid baseplate Integrity™ Implant ...
Q1 2026 Management view “In the first quarter of 2026, we made meaningful progress across Anika's three strategic priorities: driving sustainable commercial channel growth, advancing our hyaluronic ...
Anika announced fourth quarter revenue from continuing operations of $30.6 million increasing 1% compared to the same period in 2023 in line with previous guidance. Commercial Channel revenue was ...
Full Year 2024 results in line with guidance with Commercial Channel revenue up 17% Strong International OA Pain Management and greater than 40% sequential growth of Integrity Implant System drive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results